[go: up one dir, main page]

ATE410998T1 - Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut - Google Patents

Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut

Info

Publication number
ATE410998T1
ATE410998T1 AT03715039T AT03715039T ATE410998T1 AT E410998 T1 ATE410998 T1 AT E410998T1 AT 03715039 T AT03715039 T AT 03715039T AT 03715039 T AT03715039 T AT 03715039T AT E410998 T1 ATE410998 T1 AT E410998T1
Authority
AT
Austria
Prior art keywords
compound
protein kinase
cosmetically acceptable
inactivative
acceptable composition
Prior art date
Application number
AT03715039T
Other languages
English (en)
Inventor
Corinne Stoltz
Christine Garcia
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Application granted granted Critical
Publication of ATE410998T1 publication Critical patent/ATE410998T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03715039T 2002-01-25 2003-01-22 Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut ATE410998T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200925A FR2835252B1 (fr) 2002-01-25 2002-01-25 Utilisation d'un compose inactivant la proteine kinase a dans une composition contenant un milieu cosmetiquement acceptable, pour eclaicir la peau

Publications (1)

Publication Number Publication Date
ATE410998T1 true ATE410998T1 (de) 2008-10-15

Family

ID=27589581

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03715039T ATE410998T1 (de) 2002-01-25 2003-01-22 Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut

Country Status (8)

Country Link
US (2) US20050118119A1 (de)
EP (1) EP1471881B1 (de)
JP (1) JP4074254B2 (de)
AT (1) ATE410998T1 (de)
DE (1) DE60324094D1 (de)
ES (1) ES2315487T3 (de)
FR (1) FR2835252B1 (de)
WO (1) WO2003061768A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050019356A1 (en) * 2003-07-25 2005-01-27 The Procter & Gamble Company Regulation of mammalian keratinous tissue using N-acyl amino acid compositions
ATE323534T1 (de) * 2004-02-23 2006-05-15 S V R Lab Hautkosmetische zubereitungen zur depigmentierung und deren verwendung
FR2878439B1 (fr) * 2004-11-26 2007-07-20 Seppic Sa Nouveaux derives n-acyles d'aminoacides et leur utilisation en cosmetique et en pharmacie
GB0428274D0 (en) * 2004-12-23 2005-01-26 Boots Co Plc Cosmetic compositions
ATE527985T1 (de) * 2005-03-23 2011-10-15 Mary Kay Inc Zusammensetzungen zur hautaufhellung
US8758838B2 (en) * 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
US8697152B2 (en) * 2005-08-31 2014-04-15 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
FR2892020B1 (fr) * 2005-10-19 2007-12-21 Seppic Sa Composition comprenant la lauroyl proline et du laurate de sorbitan et ses utilisations dans les formulations cosmetiques et pharmaceutiques comme actif lipolytique pour une action amincissante ou anti-cellulite
FR2893841B1 (fr) * 2005-11-25 2014-04-25 Galderma Res & Dev Composition pharmaceutique depigmentante comprenant du n-(2-((3-(4-bromophenyl)-2- propenyl)amino)ethyl)-5-isoquinolinesulfonamide(h89)
JP2010515720A (ja) * 2007-01-16 2010-05-13 ザ プロクター アンド ギャンブル カンパニー 化粧品組成物
FR2921830A1 (fr) * 2007-10-03 2009-04-10 Seppic Sa Utilisation d'une combinaison du n-palmitoyl proline et d'un extrait de plante comme actif eclaircissant
CA2705573C (en) 2007-11-14 2015-06-16 Omp, Inc. Skin lightening compositions comprising arbutin
FR2936152B1 (fr) * 2008-09-24 2010-11-12 Seppic Sa Monoglyceride de n-undecylenoyl phenylalanine, procede pour sa preparation et utilisation d'esters glyceriques de n-undecylenoyl phenylalanine comme agent eclaircissant la peau.
KR101687042B1 (ko) 2009-01-16 2016-12-15 네오큐티스 에스아 칼슘 봉쇄 조성물 및 피부 색소침착 장애 및 병증의 치료 방법
FR2947276B1 (fr) * 2009-06-24 2012-10-26 Seppic Sa Composition cosmetique a base de resines echangeuses d'ions chargees avec des lipoaminoacides
FR2959746B1 (fr) 2010-05-06 2012-06-15 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible, son utilisation comme agent epaississant dans une composition cosmetique
EP2640344A1 (de) 2010-11-18 2013-09-25 The Procter and Gamble Company Kosmetische zusammensetzungen auf der basis einer n-acyl-aminosäureverbindung und hexyldecanol
KR20130095300A (ko) 2010-11-19 2013-08-27 더 프록터 앤드 갬블 캄파니 사이클로헥산-1,2,3,4,5,6-헥솔 및 n-아실 아미노산 화합물을 기재로 하는 트립신 활성을 억제 또는 감소시키기 위한 화장품 조성물 및 화장 방법
JP5932279B2 (ja) * 2011-10-07 2016-06-08 ポーラ化成工業株式会社 スクリーニング方法
US9526690B2 (en) * 2012-04-02 2016-12-27 Hypermarcas SA Depigmenting cosmetic composition and its preparation process
CN103445998B (zh) * 2012-05-29 2014-12-31 齐鲁工业大学 一种皮肤美白组合物
FR2992323B1 (fr) 2012-06-25 2015-07-03 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Nouveau latex inverse auto-inversible exempt de tensioactif, son utilisation comme agent epaississant dans une composition cosmetique
FR2992555A1 (fr) * 2012-06-28 2014-01-03 Svr Rech Combinaison dermocosmetique depigmentante et eclaircissante
EP2712629A1 (de) 2012-09-28 2014-04-02 B. Braun Melsungen AG Colloidgebundene medizinische Verbindungen
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
US9757317B2 (en) * 2014-09-12 2017-09-12 The Procter & Gamble Company Cosmetic compositions and methods for inhibiting melanin synthesis
FR3027518B1 (fr) 2014-10-24 2018-01-19 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation d'ester d'isosorbide et de derives n-acyles d'acides amines comme agent antivieillissement de la peau humaine
FR3027517B1 (fr) * 2014-10-24 2016-12-02 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Composition de mono-ester et de diester de la n-alkyl phenylalanine et de l'isosorbide, procede pour sa preparation et son utilisation comme agent eclaircissant de la peau
FR3027515B1 (fr) * 2014-10-27 2019-08-09 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation d'esters de la phenylalanine et de polyols comme agent eclaircissant de la peau du corps humain
FR3027599A1 (fr) 2014-10-27 2016-04-29 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Utilisation d'ester de derives n-acyles d'acide amines et de polyols comme agent antivieillissement de la peau humaine
US10195132B2 (en) 2016-04-25 2019-02-05 L'oréal Cosmetic composition containing combination of dispersion of acrylic and semi-crystalline polymers
US9901528B2 (en) 2016-04-25 2018-02-27 L'oréal Cosmetic composition containing combination of dispersion of acrylic polymer particles, thermoplastic elastomer and semi-crystalline polymers
CN108403545A (zh) * 2018-03-28 2018-08-17 广西秀美壮乡能源环保有限公司 一种富硒桃金娘祛斑美白液及其制备方法
FR3080031B1 (fr) 2018-04-11 2020-03-13 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation de sorbityl polyrhamnosides comme agents eclaircissants de la peau humaine

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5233168B2 (de) * 1973-01-08 1977-08-26
FR2668080B1 (fr) 1990-10-17 1993-08-13 Seppic Sa Compositions auto-emulsionnables a base d'alcools gras, leur procede de preparation et leur utilisation pour la realisation d'emulsions.
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
JP3124136B2 (ja) * 1992-11-20 2001-01-15 株式会社アドバンストスキンリサーチ研究所 メラニン生成抑制剤
JPH0853332A (ja) * 1994-08-11 1996-02-27 Kao Corp 美白化粧料
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
FR2734496B1 (fr) 1995-05-24 1997-07-04 Seppic Sa Composition emulsionnante a base d'alkylpolyglycosides, et ses utilisations
EP0925058A1 (de) 1996-09-09 1999-06-30 Societe D'exploitation De Produits Pour Les Industries Chimiques, S.E.P.P.I.C. Kosmetische verwendung von verbindungen mit einer lipoaminosäure struktur und diese enthaltende zusammensetzungen mit lindernder wirkung
FR2756195B1 (fr) 1996-11-22 1999-02-12 Seppic Sa Nouvelles compositions a base d'alkylglycosides et d'alcools gras
FR2762317B1 (fr) 1997-04-21 1999-07-09 Seppic Sa Composition a base d'alkylpolyglycosides et d'alcools gras, et ses utilisations
FR2765109B1 (fr) * 1997-06-25 2001-02-09 Seppic Sa Composition comprenant un lipoaminoacide et les constituants d'un extrait de plantes riches en tanins et utilisation en cosmetique
FR2766366B1 (fr) * 1997-07-24 2000-02-11 Seppic Sa Utilisation d'au moins un lipoaminoacide en tant qu'antagoniste de la substance p dans une formulation cosmetique pour apaiser et/ou proteger tous les types de peaux et, notamment, les peaux sensibles
FR2784680B1 (fr) 1998-09-17 2002-09-27 Seppic Sa Compositions a base d'alkylpolyglycosides et leurs utilisations et preparation d'emulsion stable a blancheur amelioree
FR2784904B1 (fr) 1998-10-22 2001-01-19 Seppic Sa Nouvelles compositions a base d'alkylpolyglycosides et d'alcools gras, notamment utiles pour la preparation d'emulsions fluides stables
FR2790977B1 (fr) 1999-03-19 2003-09-12 Seppic Sa Nouvelles emulsions eau-dans-huile stables contenant un emulsionnant a base d'oleyl- et/ou d'isostearyl-glycoside
FR2804432B1 (fr) 2000-02-01 2002-03-29 Seppic Sa Composes derives de polyglyceryl glycosides, procede pour leur preparation, composition les contenant et utilisations comme agents tensioactifs
FR2807435B1 (fr) 2000-04-06 2004-02-06 Seppic Sa Nouveaux derives de polyxylosides, procede pour leur preparation, composition en comportant et utilisation comme agents tensioactifs
JP4841075B2 (ja) * 2000-09-22 2011-12-21 旭化成ケミカルズ株式会社 美白化粧料

Also Published As

Publication number Publication date
EP1471881A2 (de) 2004-11-03
FR2835252A1 (fr) 2003-08-01
US20050118119A1 (en) 2005-06-02
FR2835252B1 (fr) 2005-08-05
US20090175811A1 (en) 2009-07-09
EP1471881B1 (de) 2008-10-15
DE60324094D1 (de) 2008-11-27
US7871635B2 (en) 2011-01-18
ES2315487T3 (es) 2009-04-01
WO2003061768A3 (fr) 2004-03-11
JP2005521658A (ja) 2005-07-21
JP4074254B2 (ja) 2008-04-09
WO2003061768A2 (fr) 2003-07-31

Similar Documents

Publication Publication Date Title
ATE410998T1 (de) Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
DK1771474T3 (da) Inhibitorer af angiopoitin-like 4 protein, kombinationer og anvendelser deraf
ATE503454T1 (de) Kosmetische zusammensetzungen und verfahren zu ihrer verwendung zur verbesserung des ästhetischen erscheinungsbilds der haut
DK1687049T3 (da) Sprøjter, sprøjtegrænseflader og sprøjtestempler til anvendelse med medicinske injektorer
NZ606294A (en) B-cell reduction using cd37-specific and cd20-specific binding molecules
ATE281431T1 (de) Resorcin-derivate
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
BRPI0414825A (pt) processo e composição de alglutinante de ureìa-formaldeìdo
BRPI0317696B8 (pt) composição para branqueamento
GT200000002AA (es) Ureas difenilicias x-carboxiaril sustituidas como inhibidores de raf quinasa
MX2007003378A (es) Control de parasitos en animales mediante el uso de nuevos derivados de trifluorometansulfonanilida oxima eter.
WO2004087896A3 (en) Hepatocyte differentiation of stem cells
ATE338528T1 (de) Verwendung von celluloseperlen zur mattierung der haut
DE602007006419D1 (de) Verfahren zur verwendung von guava-extrakt und zusammensetzung mit guava-extrakt
ATE513539T1 (de) Verwendung von wirkextrakten zur verbesserung des erscheinungsbilds von haut, lippen, haar und/oder nägeln
ATE473752T1 (de) Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung
EP1214929A3 (de) Verwendung von Polyurethanen zur Verbesserung der Wasserfestigkeit kosmetischer oder dermatologischer Formulierungen
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
DE602004015600D1 (de) Neue imidazolderivative, deren herstellung und deren verwendung als medikament
WO2005120445A3 (de) Mittel zum färben von keratinhaltigen fasern
ATE335824T1 (de) Isolierte luziferasen sowie deren verwendung
ATE345791T1 (de) Verwendung von anethol-dithiolethion zur vorbeugung von lungenkrebs
WO2006094550A8 (de) Verwendung kosmetischer zubereitungen mit einem gehalt an nicht molekular gebundenem freien sauerstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties